Revenue Growth Benchmarks
Top-line performance metrics of companies across industries and countries
Top 10 Cardiovascular Medical Device Companies
In the preceding 3 years, a significant number of leading global CVD device companies achieved double-digit growth in sales (approximately 10%). Boston Scientific, Zimmer Biomet, and Edwards Lifesciences emerged as key players in the global CVD device sector, collectively contributing to 75% of the total sales.
[ 1: LTM Sales in USD Biliion | Red Shading: Companies with negative growth in period | Green Shading: Top 2 companies by growth rank in period ]
Company | HQ | Reported | Latest | LTM | year-on-year % | CAGR | Growth Rank | ||||||||||||
Currency | FQ | Sales1 | 3m | 6m | 9m | ltm | 1y | 2y | 3y | 5y | 6m | LTM | 3ycagr | 5ycagr | |||||
Boston Scientific Corp | USA | USD | 2023-12 | 14.24 | 14.9% | 13.1% | 12.4% | 12.3% | 12.3% | 9.4% | 12.8% | 7.7% | 6 | 6 | 6 | 6 | |||
Zimmer Biomet Holdings Inc | USA | USD | 2023-12 | 7.39 | 6.3% | 5.7% | 5.4% | 6.5% | 6.5% | 4.1% | 6.5% | -1.4% | 9 | 10 | 9 | 10 | |||
Edwards Lifesciences Corp | USA | USD | 2023-12 | 6.00 | 13.8% | 13.0% | 12.5% | 11.6% | 11.6% | 7.1% | 11.0% | 10.0% | 7 | 7 | 7 | 5 | |||
Teleflex Inc | USA | USD | 2023-12 | 2.97 | 2.1% | 5.2% | 5.3% | 6.6% | 6.6% | 2.9% | 5.4% | 4.0% | 10 | 9 | 10 | 9 | |||
Integer Holdings Corp | USA | USD | 2023-12 | 1.60 | 10.9% | 14.4% | 14.3% | 16.0% | 16.0% | 14.3% | 14.2% | 5.6% | 5 | 5 | 5 | 8 | |||
Lantheus Holdings Inc | USA | USD | 2023-12 | 1.30 | 34.5% | 34.1% | 37.1% | 38.6% | 38.6% | 74.6% | 56.3% | 30.4% | 2 | 2 | 2 | 3 | |||
Merit Medical Systems Inc | USA | USD | 2023-12 | 1.26 | 10.6% | 10.2% | 9.6% | 9.2% | 9.2% | 8.2% | 9.3% | 7.3% | 8 | 8 | 8 | 7 | |||
Shockwave Medical Inc | USA | USD | 2023-12 | 0.73 | 40.9% | 41.3% | 43.7% | 49.1% | 49.1% | 75.5% | 120.9% | 126.5% | 1 | 1 | 1 | 2 | |||
Inari Medical Inc | USA | USD | 2023-12 | 0.49 | 22.6% | 26.7% | 27.2% | 28.7% | 28.7% | 33.5% | 52.3% | 135.4% | 3 | 3 | 3 | 1 | |||
iRhythm Technologies Inc | USA | USD | 2023-12 | 0.49 | 17.7% | 18.8% | 19.7% | 19.9% | 19.9% | 23.5% | 22.9% | 27.3% | 4 | 4 | 4 | 4 | |||
Source: Annual Filings, Company Website | |||||||||||||||||||
Decide Fearlessly
Aranca is a global research analytics and advisory firm with over 20 years of experience in helping organizations take strategic business and investment decisions fearlessly and with utmost conviction.
Reach out to us
© , Aranca. All rights reserved.